IDH1 and central nervous system cancer: Univariate analysis showed that tumor WHO grade, resection range, preoperative KPS score, postoperative radiotherapy and chemotherapy, IDH1/2 gene mutation and TERT promoter mutation significantly affected the postoperative survival of patients with glioma (P<0.05), as shown in Table-II.